Modern Healthcare May 24, 2018
Alex Kacik

Providers are optimistic that the health system-led generic drug company will be able to lower drug costs and mitigate shortages, and the vast majority say they will buy drugs from the venture, according to a new survey.

Intermountain Healthcare, Ascension, SSM Health and Trinity Health are working with the U.S. Department of Veterans Affairs to pool their capital and fight back against drug companies that unexpectedly hike the prices of decades-old off-patent generic drugs. The providers also want to create a more reliable supply of generic drugs like sodium bicarbonate and saline that are vulnerable to shortages.

While the health systems didn’t specify what drugs their new venture will make, they want to provide both sterile injectables and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Provider
Tenet Healthcare closes $975M sale of 4 hospitals to UCI Health
HIMSS24 Why Mass General Brigham Wants to Move 10% of Patient Care to the Home
Hospitals' cash position weakens
Which nonprofit hospitals give back the most, and least, to their communities?
Emergency Physicians Decry Surprise Air-Ambulance Bills

Share This Article